GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex® in the Treatment of Lennox-Gastaut Syndrome

[at noodls] – 28 February 2014 London, UK; 28 February 2014: GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, GW) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation … more

View todays social media effects on GWPH

View the latest stocks trending across Twitter. Click to view dashboard

See who GW is hiring next, click here to view